indacaterol
Ligand Summary
Indacaterol is a long-acting beta2-adrenergic agonist. The pharmacological effects of beta2-adrenoceptor agonist drugs, including indacaterol, are at least in part attributable to stimulation of intracellular adenyl cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3’, 5’-adenosine monophosphate (cyclic monophosphate). Increased cyclic AMP levels cause relaxation of bronchial smooth muscle.
PubChem: 6918554
Guide to Pharmacology: 7455
ChEMBL: CHEMBL1095777
DrugCentral: 4183
LyCHI: 4TS2LN8JSSNQ
Target Activities
12 Activities
Items per page:
1 – 10 of 12
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
EC50 | ||||||
EC50 | ||||||
EC50 | ||||||
EC50 | ||||||
Ki | ||||||
Ki | ||||||